CurrentRheuma
Get Weekly

Topic · page 47 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,841–1,848 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Clin Exp Rheumatol

    Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol

    Trial design

  2. Clin Exp Rheumatol

    Alpha-Klotho protein in systemic lupus erythematosus

    Cross-sectional study

  3. Clin Exp Rheumatol

    From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study

    Cohort study

  4. Clin Exp Rheumatol

    Blunted cerebral oxygenation during exercise in systemic lupus erythematosus patients

    Case-control study

  5. Clin Exp Rheumatol

    Identification of IFI44L as a new candidate molecular marker for systemic lupus erythematosus

    Mechanistic study

  6. Clin Exp Rheumatol

    Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus

    Cohort study

  7. Clin Exp Rheumatol

    Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies

    Cross-sectional study

  8. Clin Exp Rheumatol

    Metabolic disturbances in systemic lupus erythematosus evaluated with UPLC-MS/MS

    Diagnostic or prognostic study

All 1,848 Briefs in ExploreShowing Briefs 1,841–1,848 of 1,848, newest first